Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rang in aandelen #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aandeelprijs
$59.98
Laatst gesynchroniseerd: 2024-12-13
Marktkapitalisatie
$1.22B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Categorie

P/S-ratio voor Longboard Pharmaceuticals, Inc. (LBPH)
P/S-ratio op August 2026 TTM: 0.00
Volgens de meest recente financiële rapporten en aandelenkoers van Longboard Pharmaceuticals, Inc. is de huidige P/S-ratio (TTM) 0.00. Eind 2022 had het bedrijf een P/S-ratio van 0.00.
P/S-ratiohistoriek voor Longboard Pharmaceuticals, Inc. van 2020 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH